The European Medicines Agency (EMA) has approved Pfizer and BioNTech's COVID-19 vaccine Comirnaty for children between the ages of five and 11, as EU countries struggle to cope with rising
The FDA has said it needs more time to review Moderna's application for emergency use of its COVID-19 vaccine mRNA-1273 in children aged 12 to 17, as it looks at data on heart inflammation
The US looks set to see a big expansion of the country's COVID-19 vaccination drive, with shots looking likely for children aged five to 11 as well as a fourth dose for adults who are immun
FDA advisors will meet later today discuss the possibility of authorising Pfizer and BioNTech's COVID-19 vaccine Comirnaty in children as young as five years old.
The EMA has given the go-ahead to the use of Pfizer and BioNTech's COVID-19 vaccine Comirnaty as a booster for all people aged 18 or more, but says EU member states must decide for themselv
Just days after its advisory committee meeting voted to approve a third dose of Pfizer and BioNTech's COVID-19 vaccine, the FDA has followed through and cleared the shot.